Genfit S.A. (GNFTF)
USD 3.54
(-36.22%)
USD 3.54
(-36.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -28.89 Million EUR | -13.82% |
| 2022 | -25.38 Million USD | -137.74% |
| 2021 | 67.25 Million USD | 154.31% |
| 2020 | -123.84 Million USD | -69.49% |
| 2019 | -73.07 Million USD | 19.62% |
| 2018 | -90.9 Million USD | -35.84% |
| 2017 | -66.91 Million USD | -88.45% |
| 2016 | -35.51 Million USD | -90.77% |
| 2015 | -18.61 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 FY | -28.89 Million EUR | -13.82% |
| 2023 Q2 | -20.85 Million USD | -84.38% |
| 2023 Q1 | -11.31 Million EUR | 20.66% |
| 2023 Q3 | -4.24 Million EUR | 79.62% |
| 2023 Q4 | -8.03 Million EUR | -89.18% |
| 2022 Q4 | -14.25 Million USD | -118.44% |
| 2022 Q3 | -6.52 Million EUR | 37.24% |
| 2022 Q2 | -10.39 Million USD | 0.0% |
| 2022 FY | -25.38 Million USD | -137.74% |
| 2021 Q2 | 10.74 Million USD | 0.0% |
| 2021 FY | 67.25 Million USD | 154.31% |
| 2021 Q4 | 66.15 Million USD | 0.0% |
| 2020 Q2 | -59.53 Million USD | 0.0% |
| 2020 FY | -123.84 Million USD | -69.49% |
| 2020 Q4 | -58.98 Million USD | 0.0% |
| 2019 FY | -73.07 Million USD | 19.62% |
| 2019 Q2 | -58.22 Million USD | 0.0% |
| 2019 Q4 | -15.72 Million USD | 0.0% |
| 2018 FY | -90.9 Million USD | -35.84% |
| 2017 FY | -66.91 Million USD | -88.45% |
| 2016 FY | -35.51 Million USD | -90.77% |
| 2015 FY | -18.61 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioxytran, Inc. | -4.28 Million USD | -575.093% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 61.456% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -10468.321% |
| SQZ Biotechnologies Company | -79.46 Million USD | 63.639% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -898.965% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 154.539% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 144.362% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -1487.122% |
| Marizyme, Inc. | -65.34 Million USD | 55.784% |
| Genus plc | 7.9 Million USD | 465.747% |
| Pharming Group N.V. | -10.54 Million USD | -173.929% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -1231.635% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -678.765% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -226.707% |
| ContraFect Corporation | -65.15 Million USD | 55.652% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -1572.634% |
| IMV Inc. | -36.48 Million USD | 20.807% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -258.5% |
| ONE Bio Corp. | 8.67 Million USD | 433.01% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 44.104% |
| Mesoblast Limited | -87.95 Million USD | 67.149% |
| MultiCell Technologies, Inc. | -380.07 USD | -7602183.79% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -674.016% |
| Genscript Biotech Corporation | -95.47 Million USD | 69.737% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -4468.893% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -1113.59% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -339.378% |
| Biomind Labs Inc. | -1.21 Million USD | -2279.441% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -831.533% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -265.604% |
| Skye Bioscience, Inc. | -37.64 Million USD | 23.246% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -1382.314% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -165.284% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -192835.363% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -491.355% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -313.786% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -82.05% |
| Accustem Sciences Inc. | -3.74 Million USD | -671.243% |
| EV Biologics, Inc. | -1.26 Million USD | -2180.264% |
| Q BioMed Inc. | -2.05 Million USD | -1308.026% |
| GB Sciences, Inc. | -1.36 Million USD | -2021.942% |
| Alpha Cognition Inc. | -13.77 Million USD | -109.794% |
| CSL Limited | 2.64 Billion USD | 101.094% |
| Agentix Corp. | -1.37 Million USD | -2002.588% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 51.622% |
| Enzolytics Inc. | -2.17 Million USD | -1227.342% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -3.61 Million USD | -700.388% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -811.07% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -396.695% |
| argenx SE | -295.05 Million USD | 90.207% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 53.843% |
| HST Global, Inc. | -146.21 Thousand USD | -19661.986% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 29583.673% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -1546.597% |
| Halberd Corporation | -79.67 Thousand USD | -36164.371% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 517.266% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -854.815% |
| Zenith Capital Corp. | -10.59 Million USD | -172.688% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -627.26% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -596.923% |
| AVAX Technologies, Inc. | -6.41 Million USD | -350.508% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -47705.606% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1341.015% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -124218.045% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -505.847% |
| Helix BioMedix, Inc. | -1.05 Million USD | -2636.027% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -656.585% |
| Kadimastem Ltd | -3.3 Million USD | -773.617% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -240.611% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -6446.45% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -2063.646% |
| LadRx Corporation | 400.44 Thousand USD | 7315.509% |
| Cell Source, Inc. | -5.32 Million USD | -442.997% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -6854.383% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2923.036% |
| Regen BioPharma, Inc. | 1.02 Million USD | 2923.036% |
| Affymax, Inc. | -14.42 Million USD | -100.319% |
| Mobile Lads Corp. | -2.26 Million USD | -1176.636% |
| Itoco Inc. | -1.86 Million USD | -1445.965% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -550.394% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -1631.216% |
| International Stem Cell Corporation | -131 Thousand USD | -21956.489% |
| CytoDyn Inc. | -49.84 Million USD | 42.028% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -36459.412% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -12565.752% |
| Qrons Inc. | -789.34 Thousand USD | -3560.494% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -2968.838% |
| SYBLEU INC | -180.3 Thousand USD | -15925.158% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -1284.023% |
| Rebus Holdings, Inc. | -1.02 Million USD | -2732.745% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -1691.613% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -53139.239% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -1041.944% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 39.894% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -1266.793% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -3600.151% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -812.058% |
| Neutra Corp. | -233.46 Thousand USD | -12276.159% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -42.398% |
| PureTech Health plc | -65.69 Million USD | 56.019% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -35.866% |
| IXICO plc | -1.17 Million USD | -2352.801% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -191.065% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 49.422% |
| CSL Limited | 2.64 Billion USD | 101.094% |
| Cellectis S.A. | -103.17 Million USD | 71.995% |